메뉴 건너뛰기




Volumn 31, Issue 2, 2000, Pages 311-317

Cost-effectiveness of different strategies of cytomegalovirus prophylaxis in orthotopic liver transplant recipients

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; GANCICLOVIR;

EID: 0033973173     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510310208     Document Type: Article
Times cited : (24)

References (12)
  • 1
    • 0031058988 scopus 로고    scopus 로고
    • Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients
    • Falagas ME, Snydman DR, Griffith J, Ruthazer R, Werner BG, and the Boston Center for liver transplantation CMVIG study group. Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. Ann Intern Med 1997;126:275-279.
    • (1997) Ann Intern Med , vol.126 , pp. 275-279
    • Falagas, M.E.1    Snydman, D.R.2    Griffith, J.3    Ruthazer, R.4    Werner, B.G.5
  • 2
    • 0030982213 scopus 로고    scopus 로고
    • Cytomegalovirus disease is associated with increased cost and hospital length of stay among orthotopic liver transplant recipients
    • Falagas ME, Arbo M, Ruthazer R, Griffith J, Werner BG, Rohrer R, Freeman R, et al. Cytomegalovirus disease is associated with increased cost and hospital length of stay among orthotopic liver transplant recipients. Transplantation 1997;63:1595-1601.
    • (1997) Transplantation , vol.63 , pp. 1595-1601
    • Falagas, M.E.1    Arbo, M.2    Ruthazer, R.3    Griffith, J.4    Werner, B.G.5    Rohrer, R.6    Freeman, R.7
  • 4
    • 0029065431 scopus 로고
    • Randomised comparison of ganciclovir and high dose acyclovir for long-term cytomegalovirus prophylaxis in liver transplant recipients
    • Winston DJ, Wirin D, Shaked A, Busuttil. Randomised comparison of ganciclovir and high dose acyclovir for long-term cytomegalovirus prophylaxis in liver transplant recipients. Lancet 1995;346:69-74.
    • (1995) Lancet , vol.346 , pp. 69-74
    • Winston, D.J.1    Wirin, D.2    Shaked, A.3    Busuttil4
  • 5
    • 0031581506 scopus 로고    scopus 로고
    • Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver transplant recipients
    • Gane E, Saliba F, Valdecasas GJC, O'Grady J, Pescovitz MD, Lyman S, Robinson CA. Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver transplant recipients. Lancet 1997;350:1729-1733.
    • (1997) Lancet , vol.350 , pp. 1729-1733
    • Gane, E.1    Saliba, F.2    Valdecasas, G.J.C.3    O'Grady, J.4    Pescovitz, M.D.5    Lyman, S.6    Robinson, C.A.7
  • 7
    • 0021021373 scopus 로고
    • The Markov process in medical prognosis
    • Beck JR, Pauker SG. The Markov process in medical prognosis. Med Decis Making 1983;3:419-458.
    • (1983) Med Decis Making , vol.3 , pp. 419-458
    • Beck, J.R.1    Pauker, S.G.2
  • 12
    • 0029588684 scopus 로고
    • Long-term ganciclovir prophylaxis eliminates serious cytomegalovirus disease in liver transplant recipients receiving OKT3 therapy for rejection
    • Winston DJ, Imagwa DK, Holt CD, Kaldas F, Shaked A, Busuttil RW. Long-term ganciclovir prophylaxis eliminates serious cytomegalovirus disease in liver transplant recipients receiving OKT3 therapy for rejection. Transplantation 1995;60:1357-1360.
    • (1995) Transplantation , vol.60 , pp. 1357-1360
    • Winston, D.J.1    Imagwa, D.K.2    Holt, C.D.3    Kaldas, F.4    Shaked, A.5    Busuttil, R.W.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.